Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Delamanid in MDR-TB
NCT00685360Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- May 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of delamanid in Tuberculosis (TB), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started May 2008; status: completed.
02
Drugs
delamanid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00685360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685360.